# Form Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/form-bio

- Industry: Software
- Headquarters: Austin, US
- Website: www.formbio.com
- Total disclosed funding: $16M
- Latest round: Series A (Sep 12, 2022)
- Investors on record: 1

## About

Founded in 2022 and based in Texas, US, Form Bio, Inc. is a technology spinout from Colossal Biosciences, which operates as a data platform that provides workflows for scientists to help them analyze and manage data. As of 2022, Andrew Busey and Kent Wakeford are the co-CEOs of the company. In September 2022, Form Bio, Inc. raised USD 30 million in Series A funding from JAZZ Venture Partners.

The company provides data management, workflows, visualization, and collaboration. The firm offers solutions in areas such as academia, biotech, and pharma. Form Bio also offers a platform that serves as a foundation for advanced, AI-based applications to meet the needs of specific industries and academic fields.

## Funding rounds

- Series A, Sep 12, 2022, $16M — JAZZ Venture Partners

## Investors

- JAZZ Venture Partners (https://capitalatlas.ai/funds/jazz-venture-partners) — Series A